Conclusions:
Itraconazole was comparable to Methylprednisolone in preventing disease
recurrence in the post-operative management of AFRS. It may be a viable
alternative to replace systemic steroids where the latter may be
contraindicated. An oral dose of 400 mg once daily of Itraconazole given
for six weeks was safe.
Funding Source : There was no funding from any external agency.
Conflict of interest: None to declare.